La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Hansoh Pharmaceutical Group Bilan de santé
Santé financière contrôle des critères 5/6
Hansoh Pharmaceutical Group possède un total de capitaux propres de CN¥25.8B et une dette totale de CN¥4.2B, ce qui porte son ratio d'endettement à 16.4%. Son actif total et son passif total sont CN¥33.0B et de CN¥7.2B. L'EBIT de Hansoh Pharmaceutical Group est CN¥2.7B ce qui fait que son ratio de couverture des intérêts -2.8. Elle dispose de liquidités et de placements à court terme de CN¥24.9B.
Informations clés
16.4%
Ratio d'endettement
CN¥4.22b
Dette
Ratio de couverture des intérêts | -2.8x |
Argent liquide | CN¥24.88b |
Fonds propres | CN¥25.79b |
Total du passif | CN¥7.24b |
Total des actifs | CN¥33.04b |
Mises à jour récentes de la santé financière
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28Recent updates
Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 43% Above Its Share Price
Nov 07Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Oct 11A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 14Analyse de la situation financière
Passif à court terme: Les actifs à court terme de 3692 ( CN¥28.9B ) dépassent ses passifs à court terme ( CN¥6.9B ).
Passif à long terme: Les actifs à court terme de 3692 ( CN¥28.9B ) dépassent ses passifs à long terme ( CN¥381.5M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 3692 dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de 3692 est passé de 0% à 16.4% au cours des 5 dernières années.
Couverture de la dette: La dette de 3692 est bien couverte par le flux de trésorerie opérationnel ( 73.8% ).
Couverture des intérêts: 3692 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.